Cite
HARVARD Citation
Dharmapuri, G. et al. (n.d.). Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1–5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways. Leukemia research. 39 (7), pp. 696-701. [Online].